ARCHIVES

Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made

This article is from The Cancer Letter archive.

Vol. 10 No. 09 | March 2, 1984

Download PDF Visit The Full Archive

Related Articles

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget

December 7, 2012

Congressman Carter To Address ACCC Annual Conference

December 3, 1976

Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.

February 23, 2001

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

December 2, 2011